704 related articles for article (PubMed ID: 30691855)
1. Topotecan Alleviates Lipopolysaccharide-Mediated Acute Lung Injury Via the NF-κB Signaling Pathway.
Jin J; Xu W; Wan B; Wang X; Zhou Z; Miao Y; Lv T; Song Y
J Surg Res; 2019 Mar; 235():83-92. PubMed ID: 30691855
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
Liu J; Huang X; Hu S; He H; Meng Z
Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
[TBL] [Abstract][Full Text] [Related]
3. Syringic acid attenuates acute lung injury by modulating macrophage polarization in LPS-induced mice.
Wang WT; Zhang YY; Li ZR; Li JM; Deng HS; Li YY; Yang HY; Lau CC; Yao YJ; Pan HD; Liu L; Xie Y; Zhou H
Phytomedicine; 2024 Jul; 129():155591. PubMed ID: 38692075
[TBL] [Abstract][Full Text] [Related]
4. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.
Huang Y; Huang L; Zhu G; Pei Z; Zhang W
J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668
[TBL] [Abstract][Full Text] [Related]
5. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro.
Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z
Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg3 ameliorates lipopolysaccharide-induced acute lung injury in mice through inactivating the nuclear factor-κB (NF-κB) signaling pathway.
Cheng Z; Li L
Int Immunopharmacol; 2016 May; 34():53-59. PubMed ID: 26921732
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of protocatechuic acid on acute lung injury induced by lipopolysaccharide in mice via p38MAPK and NF-κB signal pathways.
Zhang X; Li C; Li J; Xu Y; Guan S; Zhao M
Int Immunopharmacol; 2015 May; 26(1):229-36. PubMed ID: 25841318
[TBL] [Abstract][Full Text] [Related]
8. Chikusetsusaponin V attenuates lipopolysaccharide-induced acute lung injury in mice by modulation of the NF-κB and LXRα.
Su K; Zhang G; Zhang X; Jiang W
Int Immunopharmacol; 2019 May; 70():174-179. PubMed ID: 30807930
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydroberberrubine attenuates lipopolysaccharide-induced acute lung injury by down-regulating MAPK, AKT, and NF-κB signaling pathways.
Yu X; Yu S; Chen L; Liu H; Zhang J; Ge H; Zhang Y; Yu B; Kou J
Biomed Pharmacother; 2016 Aug; 82():489-97. PubMed ID: 27470389
[TBL] [Abstract][Full Text] [Related]
10. The effect of magnolol on the Toll-like receptor 4/nuclear factor κB signaling pathway in lipopolysaccharide-induced acute lung injury in mice.
Yunhe F; Bo L; Xiaosheng F; Fengyang L; Dejie L; Zhicheng L; Depeng L; Yongguo C; Xichen Z; Naisheng Z; Zhengtao Y
Eur J Pharmacol; 2012 Aug; 689(1-3):255-61. PubMed ID: 22683864
[TBL] [Abstract][Full Text] [Related]
11. Asiaticoside attenuates lipopolysaccharide-induced acute lung injury via down-regulation of NF-κB signaling pathway.
Qiu J; Yu L; Zhang X; Wu Q; Wang D; Wang X; Xia C; Feng H
Int Immunopharmacol; 2015 May; 26(1):181-7. PubMed ID: 25835778
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.
Jiang Q; Yi M; Guo Q; Wang C; Wang H; Meng S; Liu C; Fu Y; Ji H; Chen T
Int Immunopharmacol; 2015 Dec; 29(2):370-376. PubMed ID: 26507165
[TBL] [Abstract][Full Text] [Related]
13. Genipin alleviates LPS-induced acute lung injury by inhibiting NF-κB and NLRP3 signaling pathways.
Zhang A; Wang S; Zhang J; Wu H
Int Immunopharmacol; 2016 Sep; 38():115-9. PubMed ID: 27262946
[TBL] [Abstract][Full Text] [Related]
14. Necrostatin-1 attenuates lipopolysaccharide-induced acute lung injury in mice.
Guan E; Wang Y; Wang C; Zhang R; Zhao Y; Hong J
Exp Lung Res; 2017; 43(9-10):378-387. PubMed ID: 29199874
[TBL] [Abstract][Full Text] [Related]
15. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of pogostone against LPS-induced acute lung injury in mice via regulation of Keap1-Nrf2/NF-κB signaling pathways.
Sun CY; Xu LQ; Zhang ZB; Chen CH; Huang YZ; Su ZQ; Guo HZ; Chen XY; Zhang X; Liu YH; Chen JN; Lai XP; Li YC; Su ZR
Int Immunopharmacol; 2016 Mar; 32():55-61. PubMed ID: 26800098
[TBL] [Abstract][Full Text] [Related]
17. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y
Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.
Ju M; Liu B; He H; Gu Z; Liu Y; Su Y; Zhu D; Cang J; Luo Z
Cell Cycle; 2018; 17(16):2001-2018. PubMed ID: 30231673
[TBL] [Abstract][Full Text] [Related]
19. Glycyrrhizin inactivates toll-like receptor (TLR) signaling pathway to reduce lipopolysaccharide-induced acute lung injury by inhibiting TLR2.
Kong D; Wang Z; Tian J; Liu T; Zhou H
J Cell Physiol; 2019 Apr; 234(4):4597-4607. PubMed ID: 30203548
[TBL] [Abstract][Full Text] [Related]
20. Suppression of NLRP3 and NF-κB signaling pathways by α-Cyperone via activating SIRT1 contributes to attenuation of LPS-induced acute lung injury in mice.
Liu X; Jin X; Yu D; Liu G
Int Immunopharmacol; 2019 Nov; 76():105886. PubMed ID: 31520990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
